Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2000
12/07/2000CA2375119A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374990A1 C-cam as an angiogenesis inhibitor
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374387A1 Adipocyte complement related protein homolog zacrp7
12/07/2000CA2374347A1 Screening method for peptides
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2373547A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2370311A1 Prevention and treatment of amyloidogenic disease
12/06/2000EP1056880A1 Methods for purified aav vector production
12/06/2000EP1056878A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056871A1 Cprot03, a human cysteine protease
12/06/2000EP1056857A2 Transporter for saccharide-coupled medicaments
12/06/2000EP1056850A2 Biotin-binding receptor molecules
12/06/2000EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
12/06/2000EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056840A1 Trans-somatics with gene transfer into mammary epithelial cells
12/06/2000EP1056834A2 Apoptotic cell-mediated antigen presentation to dendritic cells
12/06/2000EP1056780A1 Method of producing mouse and human endostatin
12/06/2000EP1056762A1 Genetic immunization with nonstructural proteins of hepatitis c virus
12/06/2000EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056478A1 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
12/06/2000EP1056473A1 Targeted delivery of biologically active media
12/06/2000EP1056467A2 Method for the treatment of diseases or disorders of the inner ear
12/06/2000EP0729506A4 Myocardial grafts and cellular compositions useful for same
12/06/2000CN1276010A CBFBGA09: a human SL15 homolog
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156736 Gene transcription and ionizing radiation: methods and compositions
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156558 Alphavirus RNA replicon systems
12/05/2000US6156537 Phospho-N-acetylmuramoyl-pentapeptide transferase of Streptococcus pneumoniae
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156497 Hybrid plasmids for the expression of heterologous proteins and irreversible genetic adjustment to tissues
12/05/2000US6156496 Suppressing microorganism propagation in eukaryotic cell; administering a blocking agent to cells to prevent suppression of kinase activity
12/05/2000US6156338 Method for preparing compositions for transferring nucleic acids
12/05/2000US6156319 Polypeptide
12/05/2000US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
12/05/2000US6156314 Monoclonal antibodies
12/05/2000US6156310 Isolated polypeptide
12/05/2000US6156304 Insertion of a genetic engineered vector into joint
12/05/2000US6156303 Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
12/02/2000CA2272055A1 Products and methods for gaucher disease therapy
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000071740A1 High specificity hairpin antisense oligonucleotides
11/30/2000WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071714A2 Methods of reducing factor viii clearance and compositions therefor
11/30/2000WO2000071707A1 A method for the diagnosis and treatment of cancer and agents useful therefor
11/30/2000WO2000071706A1 ANTISENSE TO c-myc FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
11/30/2000WO2000071703A2 Inhibition of histone deacetylase
11/30/2000WO2000071693A2 Method for selecting improved vectors
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071582A1 Fibroblast growth factor 14
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071576A2 Adenovirus vectors encoding brain natriuretic peptide
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071567A2 Fibroblast growth factor 13
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues
11/30/2000WO2000071164A1 Inhibition of gastric acid production and/or secretion
11/30/2000WO2000071152A1 Fibroblast growth factor 10
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071141A1 Modified factor viii
11/30/2000WO2000071096A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
11/30/2000WO2000071081A2 Methods of diagnosis and treatment of meniere disease
11/30/2000WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000WO2000047735A3 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
11/30/2000WO2000047615A3 Proteins related to neuronal regeneration and uses thereof
11/30/2000WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
11/30/2000WO2000042993A3 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000040605A3 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000024895A3 Method and model for hair pigmentation
11/30/2000WO2000024415A9 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374499A1 Antisense to c-myc for treatment of polycystic kidney disease
11/30/2000CA2374421A1 High specificity hairpin antisense oligonucleotides
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 870